Allogeneic Adipose Tissue Adult Mesenchymal Stromal Cell Therapy (Instituto De Investigación Sanitaria De La Fundación Jiménez Díaz)

N/A

Report date: 2023/01/12 15:46:30

Base Information

Drug NameAllogeneic Adipose Tissue Adult Mesenchymal Stromal Cell Therapy (Instituto De Investigación Sanitaria De La Fundación Jiménez Díaz)
Drug Alias NameAllogeneic and expanded adipose tissue-derived mesenchymal stromal cellsAdipose-derived Mesenchymal Stem Cells (ASC)ASCAdipose-derived Mesenchymal Stem Cells
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Source of cells > Adipose-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsPemphigoid, BullousPemphigoid, Benign Mucous MembraneConjunctivitis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInstituto De Investigación Sanitaria De La Fundación Jiménez Díaz
China Registration ClassN/A

Develop Information

Active CompaniesInstituto De Investigación Sanitaria De La Fundación Jiménez Díaz
Inactive CompaniesN/A
Active IndicationsPemphigoid, BullousPemphigoid, Benign Mucous MembraneConjunctivitis +[4] 
Inactive IndicationsRespiratory Distress Syndrome, AdultCoronavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A